ASX:NXNPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Nexsen Ltd
$0.220
Day Range
$0.220 – $0.220
52 Week Range
$0.130 – $0.345
Volume
0.00
Avg Volume (10D)
114.12K
Market Cap
$20.41M
Price Chart
OHLC · volume · moving averages
$0.220+$0.030 (+15.79%)over 6M
Hi$0.345Lo$0.140Avg Vol323.7K
Price-sensitive newsVolumePrev close · 52W rangeDrag the handles below to zoom
Market Statistics
Today's trading range
Open
$0.220
Previous Close
$0.220
Day High
$0.220
Day Low
$0.220
52 Week High
$0.345
52 Week Low
$0.130
Valuation
Fundamental multiples
Market Cap
20.41M
Shares Outstanding
92.77M
Trading Activity
Volume & order book
Volume
0.00
Value Traded
0.00
Bid
$0.215 × 286
Ask
$0.235 × 23,747
Performance
Returns across timeframes
1 Day
0.00%
5 Day
4.35%
13 Week
0.00%
YTD
50.00%
Technical Indicators
Momentum & moving averages
RSI (14)
39.24
50-Day SMA
$0.252
200-Day SMA
$0.202
— From the desk
Latest News
Biotechnology
Nexsen Secures First Asian Hospital Partner for Diagnostic Commercialisation
Nexsen signs binding term sheet with GHK Hospital to validate and roll out rapid point-of-care diagnostics in North Asia, starting with GBS and kidney tests.
Biotechnology
Nexsen Awarded $1.2m Grant to Advance Strepsure Point-Of-Care Diagnostic in Asia-Pacific Markets
Nexsen awarded $1.2m grant to advance StrepSure GBS test in Asia-Pacific; Hong Kong as hub for validation, local manufacturing and near-term commercialization.